oncology

ASLAN Partners BioGenetics To Commercialize Varlitinib

ASLAN Pharmaceuticals will focus on clinical development of varlitinib while BioGenetics will obtain the necessary regulatory approvals for the use of the drug in South Korea.

Predicting Which Cells Can Take The BiTE Out Of Cancer

Using bispecific T-cell engager technology, or BiTE, researchers in Japan have found that the cancer-killing activity of T-cells in tumors can be estimated from T-cells in the blood.

Onions And Garlic Linked To Lower Bowel Cancer Risk

A research group has found that Chinese who consumed larger amounts of onions and garlic had a lower risk of being diagnosed with colorectal cancer.

Takeda Completes Acquisition Of Shire

The acquisition of Shire allows Takeda to expand its R&D efforts in four therapeutic areas: oncology, gastroenterology, neuroscience and rare diseases.

Zai Lab Launches Field Therapy For GBM In Hong Kong

The treatment method, which relies on electric fields to destroy tumors, can now be used to treat patients in Hong Kong diagnosed with an aggressive type of brain cancer.

China Approves Home-Grown Colon Cancer Drug

Fruquintinib is the first drug discovered and developed in China to be approved by the National Medical Products Administration.

US FDA Approves LENVIMA For Unresectable Liver Cancer

Lenvatinib mesylate was shown to improve overall survival in patients with unresectable liver cancer.

Mutations More Common In Asian Lung Tumors

In Asians, lung tumors are more genetically diverse, with implications for treatment response, according to research by scientists in Singapore.

Helping Cancer Genetic Testing Go Mainstream

Community-level hospitals could help specialist centers cope with the increased volume of ovarian cancer patients seeking genetic counselling and testing.